Evidence map›Paper›PMID 34486831›Full record

ReviewEpilepsia open2022

Multi-omic strategies applied to the study of pharmacoresistance in mesial temporal lobe epilepsy.

Estela M Bruxel, Amanda M do Canto, Danielle C F Bruno, Jaqueline C Geraldis, Iscia Lopes-Cendes

Open access · goldAbstract readReview
In one paragraph

Review in Epilepsia open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Estela M BruxelDepartments of Translational Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
Amanda M do CantoDepartments of Translational Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
Danielle C F BrunoDepartments of Translational Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.
Jaqueline C GeraldisDepartments of Translational Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.ORCID 0000-0003-2188-6624
Iscia Lopes-CendesDepartments of Translational Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil.ORCID 0000-0002-6221-6822
Universidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesial temporal lobe epilepsy (MTLE) is the most common type of focal epilepsy in adults, and hippocampal sclerosis (HS) is a frequent histopathological feature in patients with MTLE. Pharmacoresistance is present in at least one-third of patients with MTLE with HS (MTLE+HS). Several hypotheses have been proposed to explain the mechanisms of pharmacoresistance in epilepsy, including the effect of genetic and molecular factors. In recent years, the increased knowledge generated by high-throughput omic technologies has significantly improved the power of molecular genetic studies to discover new mechanisms leading to disease and response to treatment. In this review, we present and discuss the contribution of different omic modalities to understand the basic mechanisms determining pharmacoresistance in patients with MTLE+HS. We provide an overview and a critical discussion of the findings, limitations, new approaches, and future directions of these studies to improve the understanding of pharmacoresistance in MTLE+HS. However, it is important to point out that, as with other complex traits, pharmacoresistance to anti-seizure medications is likely a multifactorial condition in which gene-gene and gene-environment interactions play an important role. Thus, studies using multidimensional approaches are more likely to unravel these intricate biological processes.

Indexed as

EpilepsyEpilepsy, Temporal LobeMental DisordersAdultHippocampusHumansSclerosiscomplex inheritanceepigenomicsmetabolomicsmultifactorial inheritancepharmacogenomicsproteomicstranscriptomics

Identifiers

PMID34486831
PMCPMC9340306
OpenAlexW3198632278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.